Nicholas Pharma India Limited
About Nicholas Pharma India Limited
Data last updated:
Nicholas Pharma India Limited is a public limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85100WB2021PLC244244.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Biswajit Pan and Rubi Mukhopadhyay.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kolkata, West Bengal.
As per the financials filed for FY 2023, the company reported a revenue of ₹40,000. For the same year it recorded a net profit of ₹10,390 (net margin 26%) and EBITDA of -₹25,960 (EBITDA margin -64.9%).
Company details
Contact details
Nicholas Pharma India Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 A. J. C. Bose Road, Beside Idpl, Kolkata, West Bengal, India – 700020
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nicholas Pharma India Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nicholas Pharma India Limited
FY 2025 filings availableNicholas Pharma India Limited reported revenue of ₹40,000 for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹40,000 | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹25,960 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹10,390 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -64.9% | ||
| Net Profit Margin | 26% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Nicholas Pharma India Limited, buy the company report.
Board of directors of Nicholas Pharma India Limited
Nicholas Pharma India has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Biswajit Pan Also directs: Alventa Pharma Limited, Aleris Pharmaceuticals Limited, Elder Laboratories Limited and 4 more | Director | 30 Mar 2021 | 5 Years 7 Months | Current |
| Rubi Mukhopadhyay Also directs: Smith Stanistreet Pharmaceuticals LLP, Alventa Pharma Limited, Aleris Pharmaceuticals Limited and 2 more | Director | 30 Mar 2021 | 5 Years 7 Months | Current |
| Anand Kumar Parmanandka Also directs: Alventa Pharma Limited, Aleris Pharmaceuticals Limited, Elder Laboratories Limited and 3 more | Director | 30 Mar 2021 | 5 Years 7 Months | Current |
Auditor
Nicholas Pharma India Limited is audited by H.P. JHUNJHUNWALA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| H.P. JHUNJHUNWALA & CO. | FY 2023 | 302139E |
Shareholding
The shareholding of Nicholas Pharma India Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Nicholas Pharma India Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nicholas Pharma India Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nicholas Pharma India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nicholas Pharma India Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
No GST registration is on our record for Nicholas Pharma India Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nicholas Pharma India Limited has 3 board changes on record since 2021: 3 appointments. The latest: Anand Kumar Parmanandka was appointed as Director on 30 Mar 2021.
Frequently asked questions
Nicholas Pharma India is an active public limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 March 2021 (5+ years old) and is registered under CIN U85100WB2021PLC244244.
Nicholas Pharma India has 3 current directors:
- Biswajit Pan - Director
- Rubi Mukhopadhyay - Director
- Anand Kumar Parmanandka - Director
The latest financial statements of Nicholas Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Nicholas Pharma India is U85100WB2021PLC244244. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nicholas Pharma India was incorporated on 30 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Kolkata.
Anand Kumar Parmanandka was appointed as Director on 30 Mar 2021. Biswajit Pan was appointed as Director on 30 Mar 2021. Rubi Mukhopadhyay was appointed as Director on 30 Mar 2021.
The registered office of Nicholas Pharma India is at 1 A. J. C. Bose Road, Beside Idpl, Kolkata, West Bengal, India – 700020.
Nicholas Pharma India operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Nicholas Pharma India can be reached at its registered office: 1 A. J. C. Bose Road, Beside Idpl, Kolkata, West Bengal, India – 700020.
Nicholas Pharma India is registered under the jurisdiction of the Registrar of Companies (ROC), Kolkata.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
